Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis
You'll see two new treatment options for moderate to severe plaque psoriasis, Otezla (apremilast) and Cosentyx (secukinumab).
About 20% of psoriasis patients need systemic meds added to topicals.
Be aware of the extra interactions, side effects, and monitoring.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote